Search for: "Lisa"
Results 2601 - 2620
of 13,962
Sort by Relevance
|
Sort by Date
27 Apr 2020, 3:35 am
At The NCSL Blog, Lisa Soronen discusses the effect of the coronavirus pandemic on the Supreme Court’s workload this term. [read post]
27 Apr 2020, 2:00 am
“While some industries are struggling, others are actually expanding—sometimes rapidly,” said coach Lisa. [read post]
26 Apr 2020, 10:54 am
By Lisa M. [read post]
26 Apr 2020, 12:22 am
Kat Friend Lisa Moser brought us the news about the first application of Art. 15 of the new DSM Directive in France. [read post]
25 Apr 2020, 7:28 am
All Best Wishes, Harvey – Tyler – CJ – Lisa – Dave – Joe – Gina H.- Pat – Bijal – Gina B.- Carly [read post]
24 Apr 2020, 11:06 am
By Lisa M. [read post]
24 Apr 2020, 6:58 am
As Daniel Hemel and Lisa Ouellette have written, “[g]overnments can offer strong incentives to drug makers while ensuring affordability by committing to patent buyouts for effective treatments. [read post]
24 Apr 2020, 3:54 am
Lisa Heinzerling analyzes the opinion for this blog. [read post]
24 Apr 2020, 3:00 am
National/Federal A Watchdog Out of Trump’s Grasp Unleashes Wave of Coronavirus Audits Politico – Kyle Cheney | Published: 4/20/2020 Lawmakers handed President Trump $2 trillion in coronavirus relief and then left town without activating any of the powerful new oversight tools meant to hold his administration accountable. [read post]
24 Apr 2020, 2:53 am
As many laboratories around the world are making every effort to find a treatment for Covid-19 and more clinical trials are conducted[1], it is worth considering the legal mechanisms that could facilitate the quantitatively and qualitatively sufficient, and financially acceptable, exploitation of patent rights that will prove useful in curbing the epidemic and preventing a new one. [read post]
23 Apr 2020, 10:48 am
Lisa Neubauer, '87, Keeps Seat on Court of Appeals Milwaukee Journal Sentinel [read post]
23 Apr 2020, 7:57 am
As many laboratories around the world are making every effort to find a treatment for Covid-19 and more clinical trials are conducted[1], it is worth considering the legal mechanisms that could facilitate the quantitatively and qualitatively sufficient, and financially acceptable, exploitation of patent rights that will prove useful in curbing the epidemic and preventing a new one. [read post]
23 Apr 2020, 3:00 am
Campaign Finance Oregon: “Portland Mayor Ted Wheeler Violated Campaign Finance Disclosure Rules, City Elections Official Says” by Everton Bailey Jr. for Portland Oregonian Elections Wisconsin: “Vote by Mail in Wisconsin Helped a Liberal Candidate, Upending Old Theories” by Reid Epstein for New York Times Ethics National: “The Quiet Hand of Conservative Groups in the Anti-Lockdown Protests” by Kenneth Vogel, Jim Rutenberg, and Lisa Lerer (New York Times)… [read post]
22 Apr 2020, 11:41 am
The full podcast episode is available to stream online, where listeners can also find the recent podcast “COVID-19, FIFRA, and EPA — A Conversation with Lisa Campbell” Additional updates on chemical regulatory activity related to COVID-19 can be found on B&C’s Pesticide Law and Policy Blog® and on the Regulatory Developments page of B&C's website, including these recent updates: “EPA Continues Efforts to Increase the Availability… [read post]
22 Apr 2020, 11:01 am
The full podcast episode is available to stream online, where listeners can also find the recent podcast “COVID-19, FIFRA, and EPA — A Conversation with Lisa Campbell” Additional updates on chemical regulatory activity related to COVID-19 can be found on B&C’s Pesticide Law and Policy Blog® and on the Regulatory Developments page of B&C's website, including these recent updates: “EPA Continues Efforts to Increase the Availability… [read post]
22 Apr 2020, 10:08 am
More from our authors: Vissers Annotated European Patent Convention by Derk Visser, Laurence Lai, Peter de Lange, Kaisa Suominen€ 105 Overview of the Appeal Proceedings according to the EPC, Third Edition by Hugo Meinders, Philipp Lanz, Gérard Weiss€ 95 Global Patent Protection and Enforcement of… [read post]
22 Apr 2020, 7:23 am
*s 55 and Schedule 25 of Coronavirus Act 2020 **Ss 85B and 85C of the Courts Act 2003 ***[2020] EWHC 845 (Ch) More from our authors: Vissers Annotated European Patent Convention by Derk Visser, Laurence Lai, Peter de Lange, Kaisa Suominen€ 105 Overview of the Appeal Proceedings according to the EPC, Third Edition by Hugo Meinders, Philipp Lanz, Gérard… [read post]
22 Apr 2020, 4:53 am
More from our authors: Vissers Annotated European Patent Convention by Derk Visser, Laurence Lai, Peter de Lange, Kaisa Suominen€ 105 Overview of the Appeal Proceedings according to the EPC, Third Edition by Hugo Meinders, Philipp Lanz, Gérard Weiss€ 95 Global Patent Protection and Enforcement of… [read post]
21 Apr 2020, 7:31 pm
Lisa Friedersdorf, Director of the National Nanotechnology Coordination Office (NNCO), and Dr. [read post]
21 Apr 2020, 2:09 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOur recent posts have highlighted shortages in three COVID-19-related knowledge goods: testing, drugs (such as those needed to put patients on ventilators), and clinical trial information about effective treatments. [read post]